clenbuterol Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Clenbuterol is a sympathomimetic amine used by sufferers of breathing disorders as a decongestant and bronchodilator. People with chronic breathing disorders such as asthma use this as a bronchodilator to make breathing easier. It is most commonly available as the hydrochloride salt, clenbuterol hydrochloride.   Wikipedia

Chemistry

More Chemistry

Pharmacology

Alternative names

1-(4-amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol | 4-amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol | 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol | 4-amino-α-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol | clenbuterol | (+-)-clenbuterol | (+/-)-clenbuterol | (±)-clenbuterol | clenbuterol hcl | clenbuterol hydrochloride | clenbuterolum | dl-clenbuterol | nab-365 | planipart | (rs)-clenbuterol | spiropent | spiropent mite

Organizations (14)

Research & Development (14)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (6)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (6)


 

Amyotrophic Lateral Sclerosis (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Genetic Diseases, Inborn (Phase 2)

Glycogen Storage Disease Type II (Phase 1/Phase 2)

Healthy Volunteers (Phase 2)

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 10
  • # of Trial Organizations: 14

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue